Cookies on the
LGC website
We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we’ll assume that you are happy to receive all cookies on the LGC website. However, if you would like to, you can change your cookie settings at anytime.
Question markFind out more

01 Oct LGC invests in new GMP analytical capability

Significant investment at Kulmbach site expands capacity of specialist therapeutic oligonucleotide development solutions business

01 Jun Julian Braybrook appointed UK Government Chemist

Replaces Dr Derek Craston, who completed two terms of five years each in this Office

23 Nov LGC expands Fordham site to bolster Bioanalytical and CMC capacity

First phase began in July 2017 and has just been completed

03 Apr LGC acquires Axolabs and invests in GMP manufacturing capacity for therapeutic nucleic acids

Moves strengthen existing analytical and bioanalytical drug development service offering

02 Apr LGC’s Organic Analysis Team awarded extension to ISO17025 calibration scope: qNMR for purity

Supports qNMR facility in providing reference material characterisation and quantitative measurement research for customers

17 Mar LGC helps NHS England launch a Knowledge Transfer Partnership for clinical leaders in healthcare science

Making scientific innovation an intrinsic part of delivering a world-class NHS